Taxotere side effects allegedly cause permanent hair loss. If you or a loved one have taken Taxotere, you may be entitled to compensation for your loss of hair and other related losses. We are currently working with experienced Taxotere lawyers around the country, who can file a Taxotere lawsuit on your behalf and there is no fee until you receive a settlement or award. Contact us for a free (no obligation) case evaluation online or toll free.
Local Breast Cancer Survivor Says Chemotherapy Drug Caused Permanent Hair Loss
ABC 10 News | Published on Aug 22, 2016
Abby Sandler and nearly 100 others are suing the pharmaceutical company as part of a class-action lawsuit.
Have You Sustained Permanent Hair Loss From Taking Taxotere?
Read Below On Why You May Have a Claim.
What is Taxotere?
Taxotere, also known as docetaxel, is manufactured by Sanofi-Aventis. It is a drug used for the treatment of chemotherapy for breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer. Taxotere is injected into a vein, and is member of a family of drugs called taxanes. It is used to try to prevent cancer cells from growing and dividing. Taxotere was approved by the U.S. Food & Drug Administration, or FDA, on October 17, 2006.
Are There Taxotere Lawsuits?
Lawsuits filed against Sanofi-Aventis have just begun in America, including one in California and another in Ohio for example. These complaints have accused Sanofi-Aventis of inadequate warnings to doctors and patients of possible increased risks of permanent hair loss (alopecia) because of the use of Taxotere. The cases have stated that if Sanofi-Aventis had warned of this risk, patients may have declined undergo treatments using Taxotere and may have, instead, used other comparable drugs that have been found to not cause permanent alopecia.
What Are the Common Taxotere Side Effects?
Taxotere has been linked to permanent hair loss (alopecia) in cancer patients, mainly in women being treated for breast cancer. Although Taxotere has been able to demonstrate significant success as a chemotherapy drug, it has left many patients permanently partially or completely bald, which considerably impacts their self-image and quality of life which is very important to the psychology of the patient during the recovery stage of cancer treatment.
- Substantial Hair loss (Alopecia)
- Bone, muscle or joint pain
- Fatigue and weakness
- Mouth or throat sores
- Nail changes (color changes to your fingernails or toenails)
- Peripheral neuropathy (numbness in your fingers and toes)
What Is Alopecia?
Alopecia is the medical term for hair loss. Alopecia is categorized in three different types of hair loss:
- Alopecia totalis (lose all hair on the scalp).
- Alopecia areata (hair loss in patches).
- Alopecia universalis (lose all hair on the body).
What is the FDA Doing?
In June 2014, the FDA found that Docetaxel, or brand named Taxotere, has the ability to make the users feel intoxicated during or after treatment. In early 2015, the FDA issued another warning that “Cases of permanent alopecia have been reported”. The FDA has never recalled Taxotere because of hair loss. The most recent FDA involvement includes the safety label changes being approved by the FDA.
What Are The Medical Studies Finding About Taxotere?
- A study completed in 2012 consisted of 20 Caucasian females who used Taxotere and experienced hair loss that was consistent with the pattern found in usual scalp alopecia circumstance. No natural regrowth of scalp hair was found after the usage of Taxotere by the subjects of the study, and all treatments to regrow hair proved ineffective. This was the first study to detect permanent and severe alopecia as a possible side-effect of Taxotere.
- A study presented in 2014 resulted in findings of long-term scalp alopecia which continued 3.5 years after completion of chemotherapy may affect 10-15% of patients treated with Taxotere. The study stated that permanent hair loss has a substantial impact on the quality of life of its users, and called for additional studies to determine how the hair loss side effect could be prevented while using Taxotere.
- Sanofi-Aventis has stated in a study that up to 3% of patients treated with Taxotere could experience long-term alopecia.
- The Rocky Mountain Cancer Center in Colorado has conducted a study presenting that the long-term alopecia could be found in 6.3% of Taxotere users when used with Adriamycin and Cyclophosphamide.
Why Contact Us?
If you or someone you know has suffered permanent hair loss or other side effects as a result of taking Taxotere, you may be entitled to compensation. Our law firm is currently working with some of the more experienced Taxotere attorneys in the country who are handling these cases and charge no legal fees unless you receive a settlement or award. Please contact our toll free number 24/7 at 1-800-992-6878, or fill out a contact form for a free (no obligation) case evaluation.